Pancreatic Cancer References

Last updated: 13 September 2022
Reviewed by
  1. Cascinu S, Falconi M, Valentini V, Jelic S; ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21(Suppl 5):v55-58. http://annonc.oxfordjournals.org. PMID: 20555103
  2. Dragovich T. Pancreatic cancer treatment protocols. eMedicine. http://emedicine.medscape.com.
  3. Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers. 2011 Dec;3:43-60. http://www.ncbi.nlm.nih.gov. PMID: 24212605
  4. Kim YJ, Lee WJ, Woo SM, Kim TH, et al. Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer. Radiat Oncol. 2013 Jul;8(1):160. http://www.ncbi.nlm.nih.gov. PMID: 23822606
  5. Mauro LA, Herman JM, Jaffee EM, Laheru DA. Carcinoma of the pancreas. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff's Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier Inc; 2014.
  6. Ryan DP, Mamon H. Initial chemotherapy and radiation for nonmetastatic locally advanced unresectable, borderline resectable, and potentially resectable exocrine pancreatic cancer. UpToDate. http://www.uptodate.com. May 2014.
  7. Seufferlein T, Bachet JB, Van Cutsem E, Rougier P; ESMO Guidelines Working Group. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23(7):vii33-40. http://annonc.oxfordjournals.org. PMID: 22997452
  8. World Cancer Research Fund. Cancer statistics: Data on specific cancers. Pancreatic cancer. World Cancer Research Fund. http://www.wcrf.org.
  9. Ducreux M, Cuhna AS, Caramella C, et al; ESMO Guidelines Committee. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26(Suppl 5):v56-68. doi: 10.1093/annonc/mdv295. PMID: 26314780
  10. The Singapore Cancer Network (SCAN) Pancreatic Cancer Workgroup. Singapore Cancer Network (SCAN) guidelines for systemic therapy of pancreatic adenocarcinoma. Ann Acad Med Singapore. 2015 Oct 10;44(10):388-396. http://www.annals.edu.sg. Accessed 24 Nov 2015
  11. Oettle H. Progress in the knowledge and treatment of advanced pancreatic cancer: from benchside to bedside. Cancer Treat Rev. 2014 Oct;40(9):1039-1047. doi: 10.1016/j.ctrv.2014.07.003. PMID: 25087471
  12. Ryan DP. Chemotherapy for advanced exocrine pancreatic cancer. UptoDate Web Site. http://www.uptodate.com. Jan 2016. Accessed 15 Mar 2016.
  13. American Cancer Society. Pancreatic cancer: causes, risk factors, and prevention. American Cancer Society. https://www.cancer.org/. 11 Feb 2019.
  14. American Cancer Society. Pancreatic cancer stages. American Cancer Society. https://www.cancer.org/. 18 Dec 2017.
  15. Asbun HJ, Moekotte AL, Vissers FL, et al. The Miami international evidence-based guidelines on minimally invasive pancreas resection. Ann Surg. 2020 Jan;271(1):1-14. doi: 10.1097/SLA.0000000000003590. PMID: 31567509
  16. Balaban EP, Mangu PB, Khorana AA, et al. Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016 Aug;34(22):2654-2668. doi: 10.1200/JCO.2016.67.5561. PMID: 27247216
  17. Cancer Council Australia. Optimal care pathway for people with pancreatic cancer. Cancer Council Australia. https://www.cancer.org.au/. Feb 2020.
  18. Cancer Therapy Advisor. Pancreatic adenocarcinoma treatment regimens. Cancer Therapy Advisor. https://www.cancertherapyadvisor.com/. 06 Mar 2020.
  19. ESMO Guidelines Committee. eUpdate – cancer of the pancreas treatment recommendations. ESMO. http://www.esmo.org/. 20 Jun 2017.
  20. ESMO Guidelines Committee. eUpdate – cancer of the pancreas treatment recommendations. ESMO. http://www.esmo.org/. 15 Mar 2019.
  21. Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk of familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020 Jan;69(1):7-17. doi: 10.1136/gutjnl-2019-319352. PMID: 31672839
  22. Khorana AA, McKernin SE, Berlin J, et al. Potentially curable pancreatic adenocarcinoma: ASCO clinical practice guideline update. J Clin Oncol. 2019 Aug;37(23):2082-2088. doi: 10.1200/JCO.19.00946. PMID: 31180816
  23. Lambert A, Schwarz L, Borbath I, et al. An update on treatment options for pancreatic adenocarcinoma. Ther Adv Med Oncol. 2019;11:1758835919875568. doi: 10.1177/175883591987556. PMID: 31598142
  24. Loveday BPT, Lipton L, Thomson BNJ. Pancreatic cancer: an update on diagnosis and management. AJGP. 2019 Dec;48(12):B26-B31. doi: 10.31128/AJGP-06-19-4957.
  25. Matsubayashi H, Takaori K, Morizane C, et al. Familial pancreatic cancer and surveillance of high-risk individuals. Gut and Liver. 2019 Sep;13(5):498-505. doi: 10.5009/gnl18449. PMID: 30917631
  26. National Cancer Institute. Pancreatic cancer treatment (PDQ®) - health professional version. National Cancer Institute. http: https://www.cancer.gov/. 14 Feb 2020.
  27. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. Version 1.2020. NCCN. https://www.nccn.org/. 04 Dec 2019.
  28. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): Pancreatic adenocarcinoma. Version 1.2020. NCCN. https://www.nccn.org/. 26 Nov 2019.
  29. National Institute for Health and Care Excellence (NICE). Pancreatic cancer in adults: diagnosis and management. NICE. https://www.nice.org.uk/. 07 Feb 2018.
  30. Okusaka T, Furuse J. Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines. J Gastroenterol. 2020 Apr;55(4):369-382. doi: 10.1007/s00535-020-01666-y. PMID: 31997007
  31. Palta M, Godfrey D, Goodman KA, et al. Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline. Pract Radial Oncol. 2019 Sep;9(5):322-332. doi: 10.1016/j.prro.2019.06.016. PMID: 31474330
  32. Sohal DPS, Kennedy EB, Khorana A, et al. Metastatic pancreatic cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018 Aug;36(24):2545-2556. doi: 10.1200/JCO.2018.78.9636. PMID: 29791286
  33. Aslanian HR, Lee JH, Canto MI. AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology. 2020 Jul;159(1):358-362. doi: 10.1053/j.gastro.2020.03.088. PMID: 32416142
  34. Fernandez-del Castillo C. Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer. UpToDate. https://www.uptodate.com. 17 Feb 2021.
  35. Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020 Oct;70(5):375-403. doi: 10.3322/caac.21626. PMID: 32683683
  36. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. Version 2.2021. NCCN. https://www.nccn.org/. 20 Nov 2020.
  37. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: Pancreatic adenocarcinoma. Version 2.2021. NCCN. https://www.nccn.org/. 25 Feb 2021.
  38. PDQ® Adult Treatment Editorial Board. PDQ pancreatic cancer treatment (adult). Bethesda, MD: National Cancer Institute; 2021 Feb. https://www.cancer.gov/.
  39. Sohal DPS, Kennedy EB, Cinar P, et al. Metastatic pancreatic cancer: ASCO guideline update. J Clin Oncol. 2020 Aug;38(27):3217-3230. doi: 10.1200/JCO.20.01364. PMID: 32755482
  40. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines®): Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. Version 2.2022. NCCN. https://www.nccn.org/. 09 Mar 2022.
  41. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines®): Pancreatic adenocarcinoma. Version 1.2022. NCCN. https://www.nccn.org/. 24 Feb 2022.
  42. Ryan DP. Initial systemic chemotherapy for metastatic exocrine pancreatic cancer. UpToDate. https://www.uptodate.com/. 11 Aug 2022. Accessed 11 Aug 2022.
  43. Ryan DP. Second-line systemic therapy for advanced exocrine pancreatic cancer. UpToDate. https://www.uptodate.com/. 21 Jul 2022.
  44. Sawhney MS, Calderwood AH, Thosani NC, et al. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc. 2022 May;95(5):817-826. doi: 10.1016/j.gie.2021.12.001. PMID: 35183358
  45. DeVita VT, Lawrence TS, Rosenberg SA. Devita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer; 2019.